• Request an Appointment
    Texas Oncology is ready to help you fight cancer. To schedule your first appointment, call 1-888-864-4226 or request an appointment online. Learn More.
  • Find a cancer center
    Texas Oncology has more than 150 treatment centers throughout Texas and southeastern Oklahoma. Use the map below to search for Texas Oncology centers close by. Learn More.
  • Find a physician
    Texas Oncology is a group more than 375 physicians focused on treating cancer and blood disorders. No matter where you may live in Texas or Southeastern Oklahoma, we have a physician near you. Learn More.
  • Clinical Trials
    Clinical trials allow you to access new, experimental treatments before they are widely available. Learn More.

Chawla, Jane S., M.D. PDF

Chawla, Jane S., M.D.

Provider Type: Physician



General Summary:

Jane S. Chawla, M.D., specializes in Medical Oncology and Hematology.  She is board certified in Internal Medicine, Medical Oncology and Hematology.


Dr. Chawla received a B.A. in Chemistry from Washington University in St. Louis in 2001.  She received her medical degree from the University of Texas Health Science Center in San Antonio, Texas in 2005.  She completed her residency in Internal Medicine at the University of Texas Southwestern Medical Center in Dallas, Texas in 2008.  After residency, she began her Hematology/Oncology Fellowship at Washington University in St. Louis which she completed in 2011.

Accolades & Memberships:

Dr. Chawla was Chief Hematology/Oncology Fellow at Washington University in St. Louis from 2010-2011.  As a fellow, she served on the Fellowship Education Committee from 2008-2011.  She received the VA Award for Outstanding Patient Service while a resident at the University of Texas Southwestern Medical Center in Dallas.  She is a membor of the American Society of Clinical Oncology and the American Society of Hematology.

Other Information:

As a nearly-native Texan, Dr. Chawla is a classical violinist and an avid runner.  She has run two marathons through the Leukemia Society's Team in Training.

Clinical Focus: